What is the ticker symbol for Taysha Gene Therapies?

Taysha Gene Therapies trades under the ticker TSHA on NASDAQ.

What sector does Taysha Gene Therapies operate in?

Taysha Gene Therapies is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TSHA in a portfolio?

PortView shows TSHA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Taysha Gene Therapies (TSHA) Stock Analysis

NASDAQHealthcareBiotechnology

$5.63-1.27%

1-year price historyRange $2.83 – $6.98

52-week range$5.63

$2.71$7.30

What Taysha Gene Therapies does

Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.

Key metrics

Market cap

$1.80B

P/E (TTM)

-13.40

EPS (TTM)

$-0.42

Beta

1.19

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$6.12

200-day avg

$5.42

52-week high

$7.30

52-week low

$2.71

CEO

Sean Nolan

ETFs linked to TSHA

Broad-market and Healthcare sector ETFs an investor holding Taysha Gene Therapies is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TSHA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TSHA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Taysha Gene Therapies?: Taysha Gene Therapies trades under the ticker TSHA on NASDAQ.
Which exchange is TSHA listed on?: TSHA is listed on NASDAQ.
What sector does Taysha Gene Therapies operate in?: Taysha Gene Therapies is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TSHA in a portfolio?: PortView shows TSHA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.